Support Education Research
Please leave this field empty
Scleroderma Foundation
Homepage | Forward to a Friend | Make a Donation
eletter banner.jpg
eLetter #722 | August 4, 2017  
Rheumatology Awards BookScleroderma and SSC Research Funded by Rheumatology Research Foundation

The following three grant awards were recently funded by the Rheumatology Research Foundation.  Follow the link below to read summaries of the studies.

  • Interleukin-13 and Scleroderma in African Americans, Nadia D. Morgan, M.B.B.S., Johns Hopkins University
  • Lysophospatidic Acid as a Biomarker in Systemic Sclerosis, Sara R. Schoenfeld, M.D., Massachusetts General Hospital
  • Discovering Predictors of Treatment Response in Scleroderma Lung Disease, Elizabeth R. Volkmann, M.D., M.S., University of California, Los Angeles

Read more

15th International Workshop on Scleroderma Research, August 5-9, 2017

The International Workshop on Scleroderma Research is a four-day research meeting centered on translational medicine related to systemic sclerosis which is organized and executed by the University of Pittsburgh Division of Rheumatology and Clinical Immunology and the Centre for Rheumatology and Connective Tissue Disorders at University College London (Royal Free Hospital Campus), in association with Boston University School of Medicine. The meeting covers areas key to making advances in clinical research in systemic sclerosis and is typically attended and presented by thought leaders in associated complications.

Read more
Inventiva to Present New Data on IVA337 at the 15th International Workshop on Scleroderma Research in Pittsburgh, Penn.

Read this summary of their abstract, which was hailed as one of the best papers in the upcoming workshop.

Gluten-Free Label GuideGluten-Free Diet Food Label Reading Guide

The Celiac Disease Foundation publishes a very helpful guide on reading food labels to identify gluten-free foods and to avoid foods with gluten products, including hidden sources and cross-contact.  

Read more

Pulmonary Fibrosis in Connective Tissue Disease (CTD): Urgent Challenges and Opportunities

Read this insightful article by Aryeh Fischer, M.D., a member of the Scleroderma Foundation’s National Medical and Scientific Advisory Board. 

Clinical Trial News

Cytori Releases Preliminary Data from STAR Trial

Cytori Therapeutics announced on July 24 the top-line 24- and 48-week results from the STAR trial of Habeo™ Cell Therapy in patients with scleroderma. While statistical significance was not achieved in the primary or secondary endpoints, clinically meaningful trends were observed in the pre-specified diffuse cutaneous scleroderma subgroup.

Read more

Quick Links
Contact Us
Become a Member
About Scleroderma
Calendar of Events
Online Chat
Make a gift
2016 Instagram
 actelion new.jpg
Bayer logo
Gilead Logo
reata small
Genentech Logo
Boehringer Ingelheim


Disclaimer: The Scleroderma Foundation in no way endorses any drugs, treatments, clinical trials, or studies reported in the eLetter. Information is provided to keep the readers informed. Because the manifestations and severity of scleroderma vary among individuals, personalized medical management is essential. Therefore, it is strongly recommended that all drugs and treatments be discussed with the reader’s physician(s) for proper evaluation and treatment.

Powered by Blackbaud  Unsubscribe | Visit our web site | Contact Us | Donate
300 Rosewood Drive, Suite 105, Danvers, MA 01923 tel: 800-722-HOPE (4673)
© 2019 All rights reserved.